AU652279B2 - Sustained release of hydrogen peroxide - Google Patents
Sustained release of hydrogen peroxide Download PDFInfo
- Publication number
- AU652279B2 AU652279B2 AU22753/92A AU2275392A AU652279B2 AU 652279 B2 AU652279 B2 AU 652279B2 AU 22753/92 A AU22753/92 A AU 22753/92A AU 2275392 A AU2275392 A AU 2275392A AU 652279 B2 AU652279 B2 AU 652279B2
- Authority
- AU
- Australia
- Prior art keywords
- hydrogen peroxide
- oxidase
- oxidoreductase
- substrate
- sustained release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 title claims abstract description 140
- 238000013268 sustained release Methods 0.000 title claims abstract description 20
- 239000012730 sustained-release form Substances 0.000 title claims abstract description 20
- 108010023244 Lactoperoxidase Proteins 0.000 claims abstract description 31
- 102000045576 Lactoperoxidases Human genes 0.000 claims abstract description 31
- 229940057428 lactoperoxidase Drugs 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 31
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 22
- 239000000758 substrate Substances 0.000 claims description 41
- 108010015776 Glucose oxidase Proteins 0.000 claims description 26
- 239000004366 Glucose oxidase Substances 0.000 claims description 26
- 102000004316 Oxidoreductases Human genes 0.000 claims description 26
- 108090000854 Oxidoreductases Proteins 0.000 claims description 26
- 229940116332 glucose oxidase Drugs 0.000 claims description 26
- 235000019420 glucose oxidase Nutrition 0.000 claims description 26
- 238000004519 manufacturing process Methods 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 25
- 244000005700 microbiome Species 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 235000013351 cheese Nutrition 0.000 claims description 14
- ZCZCOXLLICTZAH-UHFFFAOYSA-N hypothiocyanous acid Chemical compound OSC#N ZCZCOXLLICTZAH-UHFFFAOYSA-N 0.000 claims description 14
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims description 13
- 235000013305 food Nutrition 0.000 claims description 11
- 229920002472 Starch Polymers 0.000 claims description 9
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims description 9
- 239000008107 starch Substances 0.000 claims description 9
- 235000019698 starch Nutrition 0.000 claims description 9
- 229920000159 gelatin Polymers 0.000 claims description 8
- 235000019322 gelatine Nutrition 0.000 claims description 8
- 230000001105 regulatory effect Effects 0.000 claims description 7
- 241000588724 Escherichia coli Species 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims description 6
- 102000007070 L-amino-acid oxidase Human genes 0.000 claims description 6
- 239000004599 antimicrobial Substances 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 229940014259 gelatin Drugs 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 239000004382 Amylase Substances 0.000 claims description 5
- 108010008292 L-Amino Acid Oxidase Proteins 0.000 claims description 5
- 241000186779 Listeria monocytogenes Species 0.000 claims description 5
- 108010093894 Xanthine oxidase Proteins 0.000 claims description 5
- 102100033220 Xanthine oxidase Human genes 0.000 claims description 5
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 4
- 241000193755 Bacillus cereus Species 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 4
- 108010015133 Galactose oxidase Proteins 0.000 claims description 4
- 241000191967 Staphylococcus aureus Species 0.000 claims description 4
- 229940072056 alginate Drugs 0.000 claims description 4
- 235000010443 alginic acid Nutrition 0.000 claims description 4
- 229920000615 alginic acid Polymers 0.000 claims description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 4
- 241000607142 Salmonella Species 0.000 claims description 3
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- 239000000679 carrageenan Substances 0.000 claims description 3
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 229940113118 carrageenan Drugs 0.000 claims description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 2
- 239000001828 Gelatine Substances 0.000 claims description 2
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 claims description 2
- 230000003100 immobilizing effect Effects 0.000 claims description 2
- 238000004321 preservation Methods 0.000 claims description 2
- 102000013415 peroxidase activity proteins Human genes 0.000 claims 2
- 230000007774 longterm Effects 0.000 abstract description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 20
- 239000008103 glucose Substances 0.000 description 20
- 230000000694 effects Effects 0.000 description 15
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 14
- 239000000126 substance Substances 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 239000002245 particle Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 9
- 229950006191 gluconic acid Drugs 0.000 description 9
- 235000012208 gluconic acid Nutrition 0.000 description 9
- 241000186781 Listeria Species 0.000 description 8
- 150000002978 peroxides Chemical class 0.000 description 8
- 229920002261 Corn starch Polymers 0.000 description 7
- 239000008120 corn starch Substances 0.000 description 7
- 229940099112 cornstarch Drugs 0.000 description 7
- 230000000813 microbial effect Effects 0.000 description 7
- 235000013336 milk Nutrition 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 7
- 239000008267 milk Substances 0.000 description 7
- 108010062877 Bacteriocins Proteins 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 238000011109 contamination Methods 0.000 description 5
- 239000000174 gluconic acid Substances 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 4
- 235000006770 Malva sylvestris Nutrition 0.000 description 4
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229930182830 galactose Natural products 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 108010059892 Cellulase Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 240000002129 Malva sylvestris Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 235000021383 camembert cheese Nutrition 0.000 description 3
- 229940106157 cellulase Drugs 0.000 description 3
- 238000005202 decontamination Methods 0.000 description 3
- 230000003588 decontaminative effect Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- -1 hypothiocyanate ion Chemical class 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 239000007974 sodium acetate buffer Substances 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 3
- 235000019263 trisodium citrate Nutrition 0.000 description 3
- 229940038773 trisodium citrate Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- VRYALKFFQXWPIH-PBXRRBTRSA-N (3r,4s,5r)-3,4,5,6-tetrahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)CC=O VRYALKFFQXWPIH-PBXRRBTRSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 241000589876 Campylobacter Species 0.000 description 2
- 240000001817 Cereus hexagonus Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 2
- 241000588921 Enterobacteriaceae Species 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- OAZWDJGLIYNYMU-UHFFFAOYSA-N Leucocrystal Violet Chemical compound C1=CC(N(C)C)=CC=C1C(C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 OAZWDJGLIYNYMU-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000607734 Yersinia <bacteria> Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- PMMURAAUARKVCB-UHFFFAOYSA-N alpha-D-ara-dHexp Natural products OCC1OC(O)CC(O)C1O PMMURAAUARKVCB-UHFFFAOYSA-N 0.000 description 2
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical group [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 229940050410 gluconate Drugs 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 235000020185 raw untreated milk Nutrition 0.000 description 2
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108010035722 Chloride peroxidase Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 description 1
- 108091036429 KCNQ1OT1 Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 206010024641 Listeriosis Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000012901 Milli-Q water Substances 0.000 description 1
- 244000038561 Modiola caroliniana Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 108010053775 Nisin Proteins 0.000 description 1
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000007376 cm-medium Substances 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 235000020166 milkshake Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000004309 nisin Substances 0.000 description 1
- 235000010297 nisin Nutrition 0.000 description 1
- 239000012053 oil suspension Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000007128 oxidoreductase reaction Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
- 229940116357 potassium thiocyanate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000004460 silage Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 150000003567 thiocyanates Chemical class 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/783—Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/788—Inorganic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
Landscapes
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Dispersion Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Dairy Products (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- General Preparation And Processing Of Foods (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Fodder In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention discloses methods and means for obtaining longterm antimicrobial activity of the lactoperoxidase system. This longterm activity of the LP system is obtained by the sustained release of hydrogen peroxide. Sustained release is obtained by immobilisation of components of the LP system. Furthermore applications of this system in the conservation of foodstuffs are disclosed.
Description
OPI DATE 12/01/93 AOUP? DATE 11/03/93 k AP L ID 22753/92 I 111111IIIIII 11111ll1111 PCT NUMBER PCT/NL92/00104 ilIIilhl i ii lm mi ii i i AU9222753 '.Ja Ii U t~ L.N j11r,-' I kUtIrEI iCT) (51) International Patent Classification 5 I i' nternational Publication Number: WVO 92/22221 A23L 3/3571, A23C 19/032 C12N 11/02, A23C 19/06 (3International Publication Date: 23 December 1992 (23.12.92) (21) International Application Number: (22) International Filing Date: PCT/NL92/00 104 I I June 1992 (11.06.92) Priority data: 91201442.0 11 June 1991 (11.06.9 1) 3 4) Countries for which the regional or international application was filed:
EP
NL et al.
(74) Agents: HUYGENS, Arthur, Victor et al.; .Jist-Brocades Patents and Trademarks Department, Wateringseweg 1, P.O. Box 1, NL-2600 MA Delft (NL).
(81) Designated States: AU, CA, JP, US.
Published With international search report.
Before the expiration of the time limit for amending the claims and to be republished in the event of the receipt of amendments. (71) Applicant (for all designated States except US): GIST-BRO- CADES N.V. [NL/NL]; Wateringseweg 1, P.O. Box 1, NL-2600 MA Delft (NL).
(72) Inventors; and Inventors/Applicants (for US only) DE JONG, Sylvia, Josefine [NL/NL]; Van der Haertstraat 66, NL-2613 ZC Delft DE HAAN, Ben, Rudolf [NL/NL]; Wilgendreef 95, NL-2272 EN Voorburg TAN, Hong, Sheng [NL/NL; Buizerdstraat 94, NL-2665 TG Bleiswijk (NL).
65 ~'rn 'ek (34) 11tie, I-eirt" TERM etpi t tri !lCRO)Bhi= ACTI','IT OBTAINED BWh SUSTAINED RELEASE OF HYDROGEN PER-
OXIDE
(57) Abstract The present invention discloses methods and means f-r obtaining long-term antimicrobial activity of the lactoperoxidase system. This long-term activity of the LP system is obtained by the sustained release of hydrogen peroxide. Sustained release is obtained by immobilisation of components of the LP system. Furthermore applications of this system in the conservation of foodstuffs are disclosed.
i.- SWO 92/22221 PCT/NL92/00104 LONGTERMI ANTIMIC=ODBIAL ACTIVIT'Y OE-AI E BY .U .TAINE.'.ED SUSTAT-JEp RELEASE OF HYDROGEN PEROXIDE Technical field The present invention relatcs toan improvcmcnt in the use of an antimicrobial system. Specifioally, the invention relates to the sustained release of hydrogen peroxide. The hydrogen peroxide produced may be used as such or it may be used in combination with suitable reactants to produce substances with antimicrobial activity, specifically hypothiocyanate.
Background of the invention Microbial contamination of food and feed can cause severe health problems. Recent examples are the different outbreaks of human listeriosis that have been reported in Canada (Schlech et al. 1983. N.Engl.J.Med. 308 203-206), in the United States (Fleming et al. 1985. N.Engl.J.Med. 312 404-407 and Linnan et al. 1988. N.Engl.J.Med. 319 823-828) and in Switzerland (Food Chem. News. 1987. Dec, 7).
Microbial contamination can also adversely affect products containing proteins or other microbially degradable components.
Different methods to prevent microbial contamination of susceptible products are known such as, chemical methods (addition of compounds such as sulphite, nitrite, benzoic acid, sorbic acid) and the use of bacteriocins. Due to the suspected and prover side-effects of the chemicals used in the chemical methods, the acceptability of such methods is becoming more and more questionable. Furthermore, the applicability of bacteriocins is restricted due to the WO 92/22221 PCT/NL92/001 4 relatively high specificity of these molecules toward specific microorganisms. This would necessitate the use of mixtures of many different bacteriocins in order to be effective against microorganisms.
The disadvantages of the above-mentioned methods stimulated the search for more acceptable methods. One way to avoid the above problems is the use of naturally occurring antimicrobial systems. Turning the attention to natural mechanisms for preventing microbial growth, an antimicrobial system in milk was identified to be the so-called lactoperoxidase system (LP system). The use of this lactoperoxidase system, which has a broad range of applicability, is of increasing importance.
The lactoperoxidase/thiocyanate/hydrogen peroxide system is an antimicrobial system which is indigenous to the major body fluids such as raw milk, tears and saliva.
The properties of this; system have been reviewed by Reiter and Harnulv (1984. J. Food Protect. 47 724-732) and Pruitt and Reiter (1985. In 'The lactoperoxidase system chemistry and biological significance' Eds. Pruitt, K.M. and Tenovuo, D. p. 144-178 New York Marcel Dekker, Inc.).
Schematically, the lactoperoxidase system can be represented by a three-step process; a) the hydrogen peroxide production step; the reaction of an oxidoreductase with an oxidizable substrate with the concommitant production of hydrogen peroxide, b) the lactoperoxidase reaction step; in this step thiocyanate is converted to hypothiocyanate by reaction with hydrogen peroxide which reaction is catalyzed by lactoperoxidase, c) the antimicrobial reaction; wherein hypothiocyanate inactivates the microorganisms.
Instead of in situ production of the hydrogen peroxide, hydrogen peroxide can also be slowly added to the mixture to '4 F SWO 92/22221 PCT/NL92/00104 3 be protected. Furthermore, it is possible to use soluble inorganic peroxides from which peroxide is gradually released. For practical reasons however it is better to generate the hydrogen peroxide in situ. Preferably the hydrogen peroxide is produced enzymatically. Enzymatic production of hydrogen peroxide can be performed by using a number of different enzyme/substrate combinations, e.g. a combination of an oxidoreductase with an oxidizable substrate, for example; glucose/glucose oxidase, L amino acid/L amino acid oxidase, galactose/galactose oxidase, lactose/8-galactosidase/glucose oxidase, 2-deoxyglucose/glucose oxidase.
It is possible to add both the substrate and/or the oxidoreductase to the system which is to be protected. It is also possible to use an enzyme which is already present in the substance for which protection is sought. For example, in milk the normally present xanthine oxidase can be used to generate hydrogen peroxide by addition of hypoxanthine as a substrate. This addition of substrate is necessary to activate the system.
Combinations of different substrates and enzymes are equally effective and may give even better results. For example, the combination of glucose oxidase with Bgalactosidase can be employed in lactose containing substances, 8-galactosidase causes splitting of lactose, 30 yielding galactose and glucose, the latter carbohydrate is then further oxidized by glucose oxidase.
The antimicrobial activity of this system is due to the formation of hypothiocyanate in the following reaction; WO 92/22221 PCT/NL92/001Q4 4
H
2 0 2 SCN' H20 OSCN t lactoperoxidase lactic acid bact./ leucocytes Raw milk contains all components which are essential for this reaction; thiocyanate and lactoperoxidase are present as such and hydrogen peroxide is produced by lactic acid bacteria or leucocytes. The thiocyanate is converted into hypothiocyanous acid (HOSCN) which at the pH of milk exists mainly in the form of the hypothiocyanate ion.
It may be useful in order to prolong the activity of the LP system to add hydrogen peroxide and/or if appropriate one of the other components of the system if they are limiting to the reaction. The addition of hydrogen peroxide in turn is limited by the effects which this molecule has on the activity of the lactoperoxidase and other proteins.
The hypothiocyanate ion reacts specifically with free sulfhydryl groups, thereby inactivating several vital metabolic enzymes and membrane proteins.
The hypothiocyanate has a bacteriostatic or bactericidal effect on a wide range of microorganisms.
Activities of hypothiocyanate have been reported for example against, Pseudomonads, Enterobacteriaceae, Listeria, Yersinia, Campylobacter and Salmonella.
Milk preservation is an important application of this system. More generally, dairy products can be conserved using this system.
Other applications of the system in a more or less isolated form have been described. US patent 4,320,116 describes the use of this system in animal feedstuff and a method for treating bacterial infections in the gastrointestinal tract of mammals. Canadian patent application 1167381-A describes the use of this system in tooth-paste.
I I In general this system has the advantage of being food-grade; a wide bpectrum of possible applications can therefore be invisioned.
One of the major problems with the use of the LP system is its short working time. The literature pertaining to this system thus far only reports activity ranging from a few hours to a maximum of a few days. The major factors responsible for this short working time are; a) the uncontrolled (and high) production rate of hydrogen peroxide and, b) the high reactivity of the hydrogen peroxide.
Due to it short working time, the LP system provides only temporary protection against microbial infection. The protected substances are prone to renewed contamination and therefore the use of the LP system has been limited to date, to short term protection.
There is a need for a method of obtaining sustained release of hydrogen peroxide. The present invention provides such a system.
Summary of the Invention The present invention provides a method for obtaining sustained release of hydrogen peroxide through the reaction of at least one oxiuoreductase with its corresponding substrate characterized in that a sustained release of hydrogen peroxide is obtained by immobilizing the oxidoreductase and regulating the substrate release or production rate.
:The present invention also provides a composition 3b" having antimicrobial activity containing an oxidoreductase and a substrate whereby the oxidoreductase and/or the substrate is in an immobilized form for a sustained release of hydrogen peroxide.
The present invention further provides a composition having antimicrobial activity containing starch, amyloglucosidase, a-amylase and an oxidoreductase in an immobilized form for a sustained release of hdyrogen peroxide.
39 5 WO 92/22221 PCT/NL92/001Q4 6 Description of the figures Figures 1-15 show the effect of the LP system on the following microorganisms: Escherichia coli ATCC 11229, Salmonella typhimurium ATCC 13311, Bacillus cereus IAM 1229, Staphylococcus aureus ATCC 6538 and Listeria monocvtocenes RIVM 3 at the indicated pH values.
Figure 16 shows the effect of the lactoperoxidase system on Camembert cheese infected with Listeria.
Figure 17 shows the production of d-gluconic acid in time from free glucose and from immobilized cornstarch.
Figure 18 shows the production of gluconic acid in time using immobilized-cornstarch.
Detailed description of the invention The present invention provides a composition for use in the sustained production of hydrogen peroxide comprising an oxidoreductase and or a corresponding substrate in an immobilized form.
In its most general form, the present invention provides a method for obtaining sustained release of hydrogen peroxide by use of the composition. The hydrogen peroxide is slowly released and may be used for its antimicrobial activity as such. In order to exhibit antimicrobial activity, the hydrogen peroxide must be present in relatively large amounts. Hypothiocyanate is a much more powerful antimicrobial agent than hydrogen peroxide. Antimicrobial activity has been reported for hydrogen peroxide at a concentration of 5mM, whereas 0.02mM hydrogen peroxide has been reported to activate the LP system. The hydrogen peroxide is therefore preferably used to convert thiocyanate 4t I WQ 92/22221 PCT/NL92/00104 7 into hypothiocyanate with the use of lactoperoxidase or another peroxidase.
Any thiocyanate salt may in principle be used. Commonly alkali metal salts such as sodium or potassium thiocyanate are used.
To obtain slow release of hydrogen peroxide at least one of the components of the hydrogen peroxide generating system is immobilized. This can be the enzyme (the oxidoreductase) and/or the substrate (glucose, galactose or other substrate) corresponding to the oxidoreductase used. It is also possible to immobilize more than one component.
The composition of the present invention may contain any oxidoreductase. Preferably the oxidoreductase is selected from the group consisting of glucose oxidase, L amino acid oxidase, galactose oxidase, 8galactosidase/glucose oxidase, xanthine oxidase with a corresponding substrate. Combinations of oxidoreductases may advantageously be used in the present invention.
In the present invention the hydrogen peroxide is made available continuously and preferably at a steady-state level high enough to activate the lactoperoxidase system. To achieve this the substrate may for example be present in a slowly soluble form or it may be present in polymer form in which case the substrate molecule is only available in usable form after an enzymatic or chemical reaction.
It is also possible to couple the above hydrogen peroxide production step with another reaction step in which the substrate is generated, thereby indirectly regulating the hydrogen peroxide production rate by regulating the substrate release or production rate. An example of this is glucose which is obtained from cellulose by reaction with cellulase.
Another example is the degradation of lactose using the combination of glucose oxidase with B-galactosidase. Yet another example is the use of starch as a substrate necessitating the prior release of glucose. After release of the substrate the oxidoreductase reaction produces hydrogen WO 92/22221 PCT/NL92/001'4 -8 peroxide. It has been found that immobilization of the components provides a prolonged glucose release rate.
The hydrogen peroxide thus obtained is preferably used for increasing the effective working time of the lactoperoxidase system. We focus our discussion on the lactoperoxidase system since this system is the system of choice for food applications. However, it is recognized that other enzymes can equally well be employed according to the present invention to generate hydrogen peroxide, for example horseradish peroxidase and chloroperoxidase.
The system of the present invention can schematically be represented as follows: bound substrate (cellulose, starch enzyme, chem. reaction substrate (glucose, galactose...) oxidoreductase hydrogen peroxide peroxidase S- thiocyanate hypothiocyanate Encircled is the part of the system wherein at least one of the components is immobilized.
f To our knowledge it has not previously been attempted to use the LP system to obtain prolonged antimicrobial protection. Prolonged antimicrobial activity solves at the same time the problem of possible recontamination.
To date the LP system is generally used to treat the substance once, and subsequent reinfection is avoided by IL- 1 i W9 92/22221 PCT/NL92/00104 9 physical separation of the 'protected' substance from sources of contamination.
The present invention makes outgrowth of reinfecting microorganisms during a longer period impossible.
In case the substrate used for the enzymatic reaction is also a substrate for one of the microorganisms present in the compositions to be protected, or in case the substrate is a substrate for other infecting microorganisms, it is preferable to add the substrate in a non-metabolisable form.
Different options for using a non-metabolisable substrate present themselves; 1) the substrate can be immobilized, for example in the form of cellulose or starch. By producing and subsequently oxidizing glucose in situ, at a reaction rate that prevents accumulation, the growth of microorganisms can be prevented, 2) alternatively a non-metabolisable substrate as such can be employed; 2-deoxyglucose is an example.
The system of the present invention can be employed against a wide range of organisms. As indicated above the hypothiocyanate, which is produced in the lactoperoxidase reaction step, has been found to be active against a wide range of microorganisms including both gram-positive and gram-negative bacteria and fungi.
Activities of the hypothiocyanate have been reported for example against, Pseudomonads, Enterobacteriaceae, Listeria, Yersinia, Campylobacter, Salmonella, Streptococcus, Lactobacillus, Bacteroides, Flavobacterium and Fusobacterium.
The spectrum of activity of the present system can be increased by combining the system with other antimicrobial agents. Where apart from general protection, protection against a specific microorganism is required, it may be useful to add a bacteriocin to the system as described. This addition may be done either before or after immobilisation.
I
WO 92/22221 PCT/NL92/0010,4 10 Suitable bacteriocins are known and include lantibiotics such as nisin.
The present inventionA eMn if* 4 9- the use of the LP system against both gram-positive and gram-negative bacteria.
Specifically it is shown that the system of the present invention is effective against the following microorganisms: Escherichia coli ATCC 11229, Salmonella typhimurium ATCC 13311, Bacillus cereus IAM 1229, Staphylococcus aureus ATCC 6538 and Listeria monocytogenes RIVM 3. Tests with these microorganism have been performed at different pH between and 7. At all values the system works well, the preferred pH was 6.3.
The present invention focuses on step the second step of the three-step process described above, that is the hydrogen peroxide production 'step. In order to obtain a steady-state level of hydrogen peroxide the amount produced should be kept constant. To achieve a constant hydrogen peroxide production level, the substrate for the peroxide formation reaction can be added in a controlled manner.
Alternatively a limiting amount of enzyme, with an excess of suastrate can be used.
The invention provides a method for controllably and slowly generating the hydrogen peroxide, this is achieved by the immobilisation of the enzymes or the substrates.
Immobilisation methoas are known. Suitable methods make use of for example Calcium alginate, gelatin or carrageenan. If necessary the immobilized material can be reinforced by 30 cross-linking agents.
In the present invention some of the possible compositions are exemplified. Aviceltm (cellulose) is immobilized together with cellulase and glucose oxidase in gelatin which is subsequently cross-linked with glutardialdehyde. In this system hydrogen peroxide is produced for at least 48 hours.
lit 1 Wq92/22221 PCT/NL92/00104 11 In another example cornstarch is immobilized together with a-amylase, amyloglucosidase and glucose oxidase in a combination of gelatin and alginate, with subsequent crosslinking with glutardialdehyde. It is shown that this system is capable of releasing hydrogen peroxide for at least 42 days.
It is understood that the amounts of the components and the composition itself in the system will vary depending on the specific application. The coupling of the exemplified systems with lactoperoxidase/thiocyanate will increase the effectivity of the antimicrobial composition.
3seAe-m Miy be In liquid form minimal amounts of the LP components aseas follows; glucose oxidase (Gist-brocades) 0.8 mg/l, lactoperoxidase (Biopole) 1 mg/l, hydrogen peroxide 0.02 mM, SCN 0.02mM.
In general the molar ratio between peroxide and thiocyanate is smaller than 4 and preferably it is 1-2.
The lactoperoxidase is present in amounts varying from 1 200mg/l. Activities of the enzymes are as follows; glucose oxidase, 36.000 units/g (pH=6, T=14 0 wherein 1U= lgmol hydrogen peroxide /min, lactoperoxidase 481.000 ABTS units/g (pH=6, T=25 0
C)
(ABTS method, Childs et al. Biochem.J. (1975) 145 93- 103).
Finally the present invention discloses a food product which when treated with 102-105 microbial cells per g between 2-10 days after preparation and which is subsequently kept at normal growth conditions for the infecting microorganism does not give rise to outgrowth of this microorganism and wherein protection is due to sustained hydrogen peroxide production.
Specifically, it is also shown that the LP system is effective against Listeria, when applied on cheese (Camembert).
-9 Jtiuct- j. i uLL AlaVA. containing starch, amyloglucosidase, a-amylase and an oxidoreductase in an immobilized form for a sustained release of hdyrogen peroxide.
/2 WO 92/22221 PCT/NL92/00194 12 Specific amounts of cells and growth conditions may of course vary depending on the nature of product and the microorganism which is employed.
When practising the invention, the substance to be protected is mixed with quantities of the reagents in such a way that the hydrogen peroxide will be generated in such an amount per unit time that A a teady-state concentration is achieved.
The system as described, provides its antimicrobial protection for at least 10 days, preferably at least 20 days and more preferably up to 50 days.
Utility of the invention.
The system can be applied to food and feed conservation. With respect to this application, it can be used in a liquid, for example in (cheese-)milk, but it will be equally effective when applied to the surface of for example cheese. The system can also be applied as a longterm cleaning agent in specific applications. It is understood that the amounts of the components in the system will vary depending on the specific application.
The use of this system can be envisioned in the decontamination of carcases (bovine, fish, shrimps), surface treatment of food (cheese, butter), treatment of fresh vegetables, cosmetics, wound treatment, toothpaste, decontamination of machines (icemachines, milkshake machines) or xore broadly equipment used in food processing in plants or in area wherein food is prepared in large amounts (hospitals, restaurants and the like), decontamination of udders, silage and in feedstuff.
WO 92/22221 PCT/NL92/00104 13 Experimental Hydrocen peroxide analysis Measurement of the amount of hydrogen peroxide was performed by a modification of the method described Mottola et al. Anal. Chem. 42:410-411 (1970).
Briefly, in a 1 cm cuvet the following solutions were mixed; 50 pl sample containing hydrogen peroxide (0.2-1 mM) 200 Al leuco-crystal-violet (LCV) solution (0.5-1 mg/ml in 0.5% HC1) 1.6 ml Sodium acetate buffer (0.5 mM pH 100 pl lactoperoxidase (2 mg/ml) or HRP (Horse Radish Peroxidase) In the presence of thiocyanate, lactoperoxidase can not be used to obtain accurate measurements in this assay.
However, under these conditions horse radish peroxidase works well.
Color development was followed at 596nm.
Composition of media Minimal medium contained the following substances per liter;
K
2
HPO
4 14g; KH 2
PO
4 6g; (NH 4
)SO
4 2g; Trisodiumcitrate. 2H20, Ig; MgSO 4 7 H 2 0, 0.2mg; MnSO 4 2H 2 0, 5g; L-glutamic acid, 2g; NaOH, 0.8g; 50ml 10% Casamino acid solution (Difco), 20ml glucose solution and 10ml Vitamin solution.
Vitamin solution contained per liter; 2mg biotin; 2mg folic acid; 10mg pyridoxine HC1 B6; thiamine HC1 Bl; 5mg riboflavin B2, 5mg nicotinic acid; 0.1mg vitamin B12; 5mg p-aminobenzoic acid; 5mg DL Calciumpenthotenate.
1_1 WO 92/22221 PCT/NL92/00104 14 Cheese milk medium (CM medium) contained per liter; Caseinehydrolysate, 3g tri-sodiumcitrate, 3g lactose, 3.5g lactate, 5g tryptose and 50mM phosphate buffer (pH 5, 6 or 7).
After sterilisation glucose was added.
Examples Example 1 Activity of the lactoperoxidase system against specific microorganisms The activity of the lactoperoxidase system against five different microorganisms was tested using glucose oxidase/ glucose to generate hydrogen peroxide.
The microorganisms used were the following: Gram-negative: Escherichia coli ATCC 11229 Salmonella typhimurium ATCC 13311 Gram-positive: Bacillus cereus IAM 1229 Staphylococcus aureus ATCC 6538 Listeria monocytogenes RIVM 3 E.coli, S.tyhimurium, B.cereus and S.aureus were incubated at the desired pH in minimal medium.
L.monocytogenes was incubated in cheese milk medium.
After overnight culture the cells were used to inoculate the main culture to a density of 103-105 cells/ml. The incubation temperature was 37 0 C. The pH was 5.2, 6.3 or 7.2 (for L.monocvtogenes; 5.0, 6.0 and To these cultures the given substances were added to the indicated final concentrations: i, WO 92/22221 PCT/NL92/00104 15 SCN' 100mg/l (sodium salt, Merck); lactoperoxidase 20mg/l (Biopole); glucose-oxidase 1.5 mg/l (Gist-brocades); glucose 10 g/l (BDH).
The control cultures contained the same substances without glucose-oxidase.
The number of viable cells was followed in time and determined by plating several dilutions on BHI plates.
The hydrogen peroxide concentration was monitored during these experiments using the method outlined in Experimental. It could be concluded that using the concentrations mentioned above the hydrogen peroxide was never present in an amount sufficient to have any microbial effect as such. Thus, the antimicrobial effects described could completely be attributed to the hypothiocyanate.
Results are shown in Figures 1-15.
E.coli (Fig. 1-3) pH=7.2 cells killed between 8 and 24 hours control continues to grow after a lag phase of 4 hours pH=6.3 cells killed after 4 hours control continues to grow after 4 hours pH=5.2 cells killed after 2 hours control continues to grow after 6 hours S.typhimurium (Fig. 4-6) pH=7.2 cells killed between 6 and 24 hours control continues to grow after 4 hours pH=6.3 cells killed within 2 hours control continues to grow after 6 hours pH=5.2 cells killed after 4 hours control continues to grow after 4 hours :-IVi_ i '"4 -i i-.
a E: "1 WO 92/22221 PCT/NL92/00104 16 S.aureus (Fig. 7-9) pH=7.2 cells not completely killed control continues to grow after 8-24 hours pH=6.3 cells killed within 4 hours control as with pH=7.2 pH=5.2 cells killed within 6 hours control as with pH=7.2 (Fig. 10-12) pH=7.2 cells killed within 2 hours control continues to grow after 2 hours pH=6.3 cells killed as with pH=7.2 control continues to grow after 4 hours pH=5.2 cells killed between 6 and 24 hours control continues to grow after 6 hours B.cereus L. monocytogenes (Fig. 13-15) cells killed between 5 and 24 hours control continues to grow after 5 hours cells killed between 3 and 24 hours control continues to grow after 2 hours cells killed between 3 and 24 hours control does not grow at this pH.
It can be concluded that all tested microorganisms are adequately killed under the given experimental conditions, except for S.aureus at pH=7.2.
Overall pH=6.3 is the optimal pH.
Example 2 Sustained release of hydrogen peroxide of Avicel(tm) (a crystalline polymer constisting of cellulose, Serva) was suspended in 45 ml of an aqueous WO 92/22221 PCT/NL92/00104 17 solution of gelatin, at 30 C. Subsequently 20mg cellulase (Gist-brocades, Maxazym tm CL 2000) and 25mg glucose oxidase (Gist-brocades) were added. This gelatin-polymer-enzyme suspension was added to 100ml of a stirred cornoil (Brocacef) solution at 30°C. The water in oil suspension was cooled to The particles are cross-linked by slowly adding (in min) 1.03 g glutardialdehyde (Merck) in 8.25 ml water.
0.05g Tween 80 in 5 ml water was added and stirring was continued for 5 min.
Subsequently the particles were separated from the oil phase by addition of 1000ml water and the particles were washed twice with the same amount of water. The particles were stable and insoluble in water.
The release of hydrogen peroxide was followed in time using the method described in the Experimental section. The experiment was performed by incubating 5 g of the particles in 50ml buffer (pH=5.0) in a stirred reactor vessel at room temperature.
The results are shown in Table 1. It can be concluded that hydrogen peroxide production is sustained and constant.
Table 1. Generation of hydrogen peroxide time Cjmol H 2 0 2 /h/g particles 24 0.020 0.021 48 0.022 0.019 Example 3 Effect of the lactoperoxidase system on Camembert cheese infected with Listeria monocytoqenes Camembert cheese frozen 1 day after production was kept frozen at -50°C. Freezing and thawing had no visible effect WO 92/22221 PCT/NL92/00104 18 on the cheese flora. Cheeses were put in refrigerator boxes with a volume of 1 liter and the relative humidity was kept at 95% using a glycerol/water mixture.
The boxes were incubated at 14 0 C. After 5 days cheeses were treated with Listeria monovtoqenes USM 20600 at 100 cells per gram cheese (in 0.5ml). After 4 hours the cheeses were treated at one side with 0.6ml of LPS solution (100mM glucose (BDH), 20mM NaSCN (Merck), 200mg/l lactoperoxidase (Biopole) and 50mg/l glucose oxidase (Gist-brocades)).
Control cheeses were treated with milli-Q water.
The number of Listeria were counted at t=0 and after 1, 2 and 5 days in duplo. Counting was performed by diluting 17 g of cheese two times in 2% tri-sodiumcitrate. After homogenisation in a Stomacher the suspension was diluted in a physiological salt solution.
0.1 ml of different dilutions were brought onto Palcam plates (Merck). Plates were grown at 30 0 C during one day and colonies were counted.
The result is shown in Figure 16 and it can be concluded that the LPS system works well under application conditions.
Example 4 Use of immobilized cornstarch as a glucose source I A suspension consisting of 10% cornstarch in 8% gelatin and 1% alginate was prepared. The mixture was kept at 30 C and 0.05% a-amylase (Gist-brocades, Maxamyl 1 m, 6300 TAU/g), 0.05 amyloglucosidase (Gistbrocades, Amigaset m TS, 25000 AGI/ml) and 0.05% glucose oxidase (Gist-brocades) (all on w/w basis) were added.
Subsequently the suspension was poured into two volumes of cornoil containing 1% Span 80. The mixture was heavily stirred using a turbin rotor. After 5 minutes the WO 92/22221 PCT/NL92/00104 19 temperature was lowered to 15 0 C and after coagulation 8.25 ml cross-link mixture was added per 50 g of formulation.
Cross-link mixture consisted of 88.5% Cacl 2 2H 2 0 in ethanol g per 100ml ethanol) and 11.5% glutardialdehyde w/w).
After 60 minutes the immobilisation product-oil emulsion was stirred in an excess water for 5 minutes and the oil was decanted. The immobilisation product was subsequently washed twice with an excess of water and finally isolated by fractionated sieving.
In order to follow the hydrogen peroxide production rate production of gluconic acid was measured. Gluconate is a product of the hydrogen peroxide forming reaction: glucose 02 H 2 0 2 gluconate Two open, stirred 100ml reaction vessels were used to follow the D-gluconic acid production at room temperature.
Vessel one contained 2.5 g of immobilisation product in 25 ml 0.1 M sodium acetate buffer, pH Vessel two contained 0.277 g glucose and 1,38 g glucose oxidase in 25 ml 0.1 M sodium acetate buffer, pH D-gluconic acid was measured using an enzymatic test kit from Boehringer Mannheim (cat. no. 428.191).
The results are presented in Figure 17 it can be seen that without immobilisation and use of free glucose the Dgluconic acid production stops after about 50 hours whereas 3 30 D-gluconic acid production and hence hydrogen peroxide production continues for more than 200 hours when immobilized starch is used as glucose source.
The maximum amount of gluconic acid which could be obtained from the amount of starch used in this experiment was 60 mM.
WO 92/22221 PCT/NL92/00104 20 Example Use of immobilized cornstarch as a glucose source II 50 g of cornstarch was suspended in 200 ml water and heated to 850C. The slurry was kept at this temperature for minutes with continues stirring. A solution of 50 g gelatine in 200 ml was added. After cooling the suspension to about 40 0 C, 125 mg amyloglucosidase (Amigasetm TS), 250 mg glucose oxidase and 1250 mg lactoperoxidase were added.
Thereafter 6 ml glutardialdehyde (25% w/w) was added with continuous stirring. The gel was homogenized with a blender.
After homogenisation 2 1, 0.2 M sodium acetate containing 0.7% glutardialdehyde was added. The mixture was stirred for 15 minutes at 15 0 C. The product was sieved and washed twice with a tenfold volume of water. The product was subsequently dried in a fluid bed dryer at 39 0 C to 94% dry weight.
Finally the dried particles were milled in a high speed hammer mill to a particle size of approximately 20 microns.
150 mg of the dried particles (20 microns) was suspended in 149 ml 0.1 M sodiumphosphate buffer containing 4.5% NaCl and 1.0 ml 400 mM NaSCN.
Incubation was in a shaking waterbath at 7 0 C with such a speed that the particles were kept in constant motion and that aeration was assured. Gluconic acid production was followed in time using the previously mentioned Boehringer test kit.
Figure 18 shows the results. Under the given conditions hydrogen peroxide can be generated for at least 42 days at a constant rate.
The maximum amount of gluconic acid which could be obtained from the amount of starch used in this experiment was 3 mM.
Claims (19)
1. A method for obtaining sustained release of hydrogen peroxide through the reaction of at least one oxidoreductase with its corresponding substrate characterized in that a sustained release of hydrogen peroxide is obtained by immobilizing the oxidoreductase and regulating the substrate release or production rate.
2. A method according to claim 1, characterized in that the immobilization is performed with gelatin, alginate, carrageenan.
3. A method according to claim 1 or 2 wherein the oxidoreductase is selected from the group consisting of glucose oxidase, L amino acid oxidase, galactose oxidase, B-galactosidase/glucose oxidase and xanthine oxidase.
4. A method according to any one of the previous claims wherein a combination of at least two S oxidoreductases is employed.
The method of any one of the previous claims S wherein the hydrogen peroxide is used to convert thiocyanate into hypothiocyanate in the presence of a peroxidase.
6. The method of claim 5 wherein the peroxidase is lactoperoxidase. S*
7. Use of the method of any one of the previous claims as an antimicrobial system in the preservation of food or feed.
8. Use of the method of claim 7 in the conservation of cheese. 39 21 lI
9. Use of the method of claim 7 against gram-positive or gram-negative bacteria or fungi.
Use of the method of claim 9 against the following microorganisms; Escherichia coli, Salmonella tvphimurium, Bacillus cereus, Staphylococcus aureus or Listeria monocytogenes.
11. Use of an immobilized oxidoreductase in combination with a substrate in a form which allows regulating the substrate release or production rate to provide for sustained release of hydrogen peroxide.
12. Use according to claim 11 wherein the oxidoreductase is selected from the group consisting of glucose oxidase, L amino acid oxidase, galactose oxidase and B-galactosidase/glucose oxidase and xanthine oxidase.
13. A composition having antimicrobial activity containing an oxidoreductase and a substrate whereby the oxidoreductase and/or the substrate is in an immobilized form for regulating the substrate release to provide for sustained release of hydrogen peroxide.
14. A composition according to claim 13 chacterized in that the oxidoreductase is selected from the group consisting of glucose oxidase, L amino acid oxidase, glactose oxidase and 8-galactosidase/glucose oxidase and xanthine oxidase.
15. A composition having antimicrobial activity containing starch, amyloglucosidase, a-amylase and an G- oxidoreductase in an immobilized form for regulating the substrate release to provide for sustained release of hydrogen peroxide.
16. A composition according to claim 15, wherein the components are immobilized in alginate, gelatine or carrageenan. 39 22
17. A food product containing a composition according to any one of the claims 13 to 16.
18. A cheese containing a composition according to any one of the claims 13 to 16.
19. A method according to claim 1 substantially as hereinbefore described with reference to any one of the examples or accompanying drawings. DATED: 30 March, 1994 0*e PHILLIPS ORMONDE FITZPATRICK Attorneys for: GIST-BROCADES N.V. I ;4 6194V 23 i
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP91201442 | 1991-06-11 | ||
| EP91201442 | 1991-06-11 | ||
| PCT/NL1992/000104 WO1992022221A1 (en) | 1991-06-11 | 1992-06-11 | Long-term antimicrobial activity obtained by sustained release of hydrogen peroxide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2275392A AU2275392A (en) | 1993-01-12 |
| AU652279B2 true AU652279B2 (en) | 1994-08-18 |
Family
ID=8207712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU22753/92A Ceased AU652279B2 (en) | 1991-06-11 | 1992-06-11 | Sustained release of hydrogen peroxide |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0518445B1 (en) |
| JP (1) | JPH06500700A (en) |
| AT (1) | ATE136740T1 (en) |
| AU (1) | AU652279B2 (en) |
| CA (1) | CA2083275C (en) |
| DE (1) | DE69209894T2 (en) |
| IE (1) | IE74397B1 (en) |
| NZ (1) | NZ243106A (en) |
| WO (1) | WO1992022221A1 (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8178090B2 (en) | 1995-06-07 | 2012-05-15 | Danisco A/S | Recombinant hexose oxidase |
| US7745599B1 (en) | 1995-06-07 | 2010-06-29 | Danisco A/S | Hexose oxidase-encoding DNAs and methods of use thereof |
| GB9913050D0 (en) * | 1999-06-04 | 1999-08-04 | Danisco | Anti-fouling composition |
| FR2750575B1 (en) * | 1996-07-04 | 1998-11-13 | Labeyrie Sa | PROCESS FOR DECONTAMINATION OF PRODUCTS OF AQUACULTURAL ORIGIN |
| US6342386B1 (en) * | 1996-10-29 | 2002-01-29 | Warren Paul Powers | Methods for removing undesired growth from a surface |
| JPH10259326A (en) * | 1997-03-17 | 1998-09-29 | Nippon Paint Co Ltd | Method for sustained release of compound having antibiotic activity and coating composition |
| GB2370486A (en) * | 1998-08-28 | 2002-07-03 | Univ Bath | Ingestible compositions comprising antibacterial agents |
| AU5526399A (en) * | 1998-08-28 | 2000-03-21 | University Of Bath, The | Improvements in or relating to the treatment of lesions |
| DE60034368T2 (en) | 1999-12-28 | 2008-01-03 | Kimberly-Clark Worldwide, Inc., Neenah | USE DEPENDENT INDICATOR SYSTEM FOR ABSORBENT ARTICLES |
| BR0016354B1 (en) | 1999-12-28 | 2012-09-18 | Method of forming an antimicrobial cleaning cloth and cleaning cloth. | |
| US6734157B2 (en) | 1999-12-28 | 2004-05-11 | Kimberly-Clark Worldwide, Inc. | Controlled release anti-microbial hard surface wiper |
| JP4177949B2 (en) * | 2000-03-28 | 2008-11-05 | 雪印乳業株式会社 | Vegetable washing and sterilization methods |
| FR2825373B1 (en) * | 2001-05-31 | 2004-04-30 | Tmi Europ | PROCESS FOR THE ENZYMATIC PRODUCTION OF A FLUID TREATMENT AGENT |
| US8080404B1 (en) * | 2005-04-05 | 2011-12-20 | The United States Of America As Represented By The Secretary Of The Army | Enzymatic decontamination |
| JP4203120B2 (en) * | 2007-02-28 | 2008-12-24 | 森永乳業株式会社 | Bactericide for oral cavity and food additive containing the bactericide |
| CA2658440C (en) | 2008-04-04 | 2016-08-23 | Kraft Foods Global Brands Llc | Dairy composition with probiotics and anti-microbial system |
| RU2665094C2 (en) * | 2013-08-06 | 2018-08-28 | Биенка Н.В. | Antimicrobial compositions and use thereof in food preservation |
| NZ726323A (en) | 2014-04-30 | 2020-02-28 | Matoke Holdings Ltd | Antimicrobial compositions |
| GB2552572B (en) * | 2014-04-30 | 2019-01-16 | Matoke Holdings Ltd | Antimicrobial compositions |
| BR112019006932A2 (en) * | 2016-10-06 | 2019-07-02 | Matoke Holdings Limited | antimicrobial compositions |
| GB201716986D0 (en) | 2017-10-16 | 2017-11-29 | Matoke Holdings Ltd | Antimicrobial compositions |
| CN113412901A (en) * | 2021-07-13 | 2021-09-21 | 广州沃邦生物科技有限公司 | Coco ferment pseudomonas antibacterial composition and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0397228A1 (en) * | 1989-05-12 | 1990-11-14 | Bio Serae Laboratoires Sa | Decontamination process for non-liquid food product, particularly cheese and composition for the same |
| EP0397227A1 (en) * | 1989-05-12 | 1990-11-14 | Bio Serae Laboratoires Sa | Method of preparation of an antimicrobial particulate, its product and applications |
| AU637585B2 (en) * | 1988-10-28 | 1993-06-03 | Stabra Ag | Glucose oxidase food treatment and storage method |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE789195A (en) * | 1971-09-24 | 1973-03-22 | Gist Brocades Nv | ENZYME COMPOSITIONS |
| SE375224B (en) * | 1973-07-19 | 1975-04-14 | Alfa Laval Ab | |
| SE420793B (en) | 1976-03-08 | 1981-11-02 | Astra Ewos Ab | FEEDING AGENT CONTAINING AN ANTI-BACTERIAL SYSTEM |
-
1992
- 1992-06-11 JP JP5500812A patent/JPH06500700A/en active Pending
- 1992-06-11 AU AU22753/92A patent/AU652279B2/en not_active Ceased
- 1992-06-11 EP EP92201722A patent/EP0518445B1/en not_active Expired - Lifetime
- 1992-06-11 AT AT92201722T patent/ATE136740T1/en not_active IP Right Cessation
- 1992-06-11 DE DE69209894T patent/DE69209894T2/en not_active Expired - Fee Related
- 1992-06-11 WO PCT/NL1992/000104 patent/WO1992022221A1/en not_active Ceased
- 1992-06-11 NZ NZ243106A patent/NZ243106A/en unknown
- 1992-06-11 CA CA002083275A patent/CA2083275C/en not_active Expired - Fee Related
- 1992-07-01 IE IE921889A patent/IE74397B1/en not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU637585B2 (en) * | 1988-10-28 | 1993-06-03 | Stabra Ag | Glucose oxidase food treatment and storage method |
| EP0397228A1 (en) * | 1989-05-12 | 1990-11-14 | Bio Serae Laboratoires Sa | Decontamination process for non-liquid food product, particularly cheese and composition for the same |
| EP0397227A1 (en) * | 1989-05-12 | 1990-11-14 | Bio Serae Laboratoires Sa | Method of preparation of an antimicrobial particulate, its product and applications |
Also Published As
| Publication number | Publication date |
|---|---|
| NZ243106A (en) | 1994-09-27 |
| EP0518445A1 (en) | 1992-12-16 |
| DE69209894T2 (en) | 1996-09-05 |
| CA2083275A1 (en) | 1992-12-12 |
| EP0518445B1 (en) | 1996-04-17 |
| WO1992022221A1 (en) | 1992-12-23 |
| DE69209894D1 (en) | 1996-05-23 |
| IE74397B1 (en) | 1997-07-30 |
| IE921889A1 (en) | 1992-12-16 |
| AU2275392A (en) | 1993-01-12 |
| JPH06500700A (en) | 1994-01-27 |
| ATE136740T1 (en) | 1996-05-15 |
| CA2083275C (en) | 2003-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU652279B2 (en) | Sustained release of hydrogen peroxide | |
| US5747078A (en) | Longterm antimicrobial activity obtained by sustained release of hydrogen peroxide | |
| Tiina et al. | Antibacterial effect of the glucose oxidase-glucose system on food-poisoning organisms | |
| Hughey et al. | Antimicrobial activity of lysozyme against bacteria involved in food spoilage and food-borne disease | |
| US5085873A (en) | Process for the treatment of a non-liquid food product for assuring its microbial decontamination | |
| EP0022341B1 (en) | Method and starter compositions for the growth of acid producing bacteria and bacterial compositions produced thereby | |
| Villegas et al. | Hydrogen peroxide production by Lactobacillus delbrueckii subsp. lactis I at 5 C | |
| NO149197B (en) | PROCEDURE FOR THE MANUFACTURING OF FOODS CONTAINING AN ANTIBACTERIAL SYSTEM | |
| Ozturk et al. | The antimicrobial activity of bovine milk xanthine oxidase | |
| Dave et al. | Characteristics of bacteriocin produced by Lactobacillus acidophilus LA-1 | |
| Dobbenie et al. | Antibacterial activity of the glucose oxidase/glucose system in liquid whole egg | |
| NO174793B (en) | Use of an efficient combination of nisin and lysozyme to inhibit the growth of unwanted microorganisms | |
| JPH11113502A (en) | Feed for adding drinking water for birds and feeding method thereof | |
| Wyss | Microbial inhibition by food preservatives | |
| US6893670B2 (en) | Cheese ripening process | |
| EP0063438A1 (en) | Production of powder containing bacteria and product thereof | |
| Massa et al. | Growth inhibition by glucose oxidase system of enterotoxic Escherichia coli and Salmonella derby: in vitro studies | |
| Wang et al. | Inactivation and regeneration of immobilized catalase | |
| Lloyd‐George et al. | Characterization of free and alginate–polylysine–alginate microencapsulated Erwinia herbicola for the conversion of ammonia, pyruvate, and phenol into l‐tyrosine | |
| NL1020301C2 (en) | Production of a probiotic preparation comprises incubating a probiotic microorganism and a metabolizable substrate with an aqueous liquid | |
| Marie et al. | Characterization of bacteriocin produced by Lactobacillus rhamnosus 1K isolated from traditionally fermented milk in the western highlands region of Cameroon | |
| Molin | Mixed carbon source utilization of meat-spoiling Pseudomonas fragi 72 in relation to oxygen limitation and carbon dioxide inhibition | |
| CA1282723C (en) | Method for increasing the milk clotting activity of thermolabile rhizomucor pussillus rennet | |
| Santos et al. | Antibacterial activity of the lactoperoxidase system against Aeromonas hydrophila in broth, skim milk and ewes' milk | |
| PT86606B (en) | PROCESS FOR THE PREPARATION OF AN ENZYME PRODUCT ORIGINATING IN STREPTOMICETES AND FOR THE CONSERVATION OF CHEESE FOR THE USE OF THESE PRODUCTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Assignment registered |
Owner name: DSM IP ASSETS B.V. Free format text: FORMER OWNER WAS: DSM N.V. |